TrialBritish journal of cancer2004

Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma.

M Lotem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.